Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea.

Conclusions NOMAC/E2 was effective in reducing most premenstrual and menstrual symptoms, and was associated with significantly greater improvements in many MDQ-C domain scores compared with DRSP/EE. ( ClinicalTrials.gov : NCT00413062 and NCT00511199). PMID: 25712537 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25712537?dopt=Abstract

Source: The European Journal of Contraception and Reproductive Health Care - February 25, 2015 Category: Reproduction Medicine Authors: Witjes H, Creinin MD, Sundström-Poromaa I, Martin Nguyen A, Korver T Tags: Eur J Contracept Reprod Health Care Source Type: research